By Canterbury Consulting
Watch exclusive videos from our fireside chat with Dr. Robert M. Califf, former commissioner at the U.S. Food & Drug Administration and now head of clinical policy and strategy for Verily and Google Health, as we discuss what his notes on vaccine development and deployment, the future of COVID-19, and how the U.S. will…

By Poorvi Parekh, CFA
The year 2020 will be remembered as a year marked by crisis as well as the heroic responses that crossed national and regional boundaries. While the year began with steady growth, in March, the COVID-19 pandemic quickly shaped into a global crisis. This forced populations to engage in some form of isolation, distancing…

By Emmett Shiras, CFA, CAIA
This blog post examines the use and benefits of dividends and share buybacks in the United States and Europe, as well as the significant impact of COVID-19 on these forms of profit distribution. Furthermore, we compare the shareholder yield metric, which is a more complete measure of shareholder return, to the dividend…